KLOW, BPC-157, TB-500, KPV and GHK-Cu are not FDA-approved treatments for injury recovery, inflammation, digestive disorders, skin rejuvenation, hair growth, anti-aging or general wellness
Each plot shows the marginal probabilities for signal peptide regions
Wang, Q., Lv, H., Lu, L., Ren, P
Pregnant or breastfeeding women safety unknown Cancer patients or those with tumor history due to VEGF promotion, angiogenesis could theoretically support tumor growth Autoimmune disorders while BPC-157 is generally anti-inflammatory, immune modulation can vary by individual Angiogenic peptides may pose theoretical risks in neoplastic conditions by promoting blood vessel formation
In some cases, surgery may be necessary to alleviate symptoms and prevent further damage